Headquarters
USA

Avellino Labs

Avellino’s mission is to ethically and securely collect, organize and share genetic data to maximize its predictive diagnostic and therapeutic benefits to accelerate positive outcomes for individuals worldwide. As a global leader in leveraging artificial intelligence-powered algorithms, Avellino’s diagnostics provide eye care professionals with personalized genetic data to predict eye disease, prevent disease progression and preserve vision. Its R&D team has made groundbreaking discoveries in early detection of oncology, a polygenic risk score for glaucoma, and a siRNA gene-silencing therapeutic for the treatment of granular corneal dystrophy type II. Avellino is headquartered in California, with operations in Korea, Japan and the United Kingdom.

Visit the Avellino Labs website

1 articles from Avellino Labs

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum